CBLB-613

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCBLB-613
Drug Alias NameCBLB-613
ClassificationBiologics
Mechanisms of ActionToll like receptor 6 agonistsToll like receptor 2 agonists
TargetsToll like receptor 6Toll like receptor 2
Therapy Area/IndicationsRadiation sickness
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesStatera Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStatera Biopharma Inc
Active IndicationsN/A
Inactive IndicationsRadiation sickness

Other Information

ATC CodeN/A
Related LinksN/A